Trial reportToxins2018
Botulinum Neurotoxin Injection for the Treatment of Recurrent Temporomandibular Joint Dislocation with and without Neurogenic Muscular Hyperactivity.
Trial report in Toxins, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07385742 (A Comparative Study Between Botulinum Toxin Versus Platelet Rich Fibrin Injection for Treatment of Temporomandibular Joint Internal Derangement), which is not on this map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Comparative Study Between Botulinum Toxin Versus Platelet Rich Fibrin Injection for Treatment of Temporomandibular Joint Internal Derangement
Who cites it
21 citing papers in PubMed, 42 citations in OpenAlex.
- The effects of botulinum toxin A injection on the lateral pterygoid muscle in patients with a painful temporomandibular joint click: a randomized clinical trial study.BMC oral health · 2022Trial
- A new medication-free technique for the reduction of acute atraumatic anterior temporomandibular joint dislocation.Emergency medicine journal : EMJ · 2026Article
- Management of Recurrent Temporomandibular Joint Dislocation in Children: A Systematic Review.Journal of clinical medicine · 2025Review
- The Effective Way of Botulinum Toxin Injection to Reduce Bite Force: Preliminary Study.Toxins · 2025Article
- Long-Standing Temporomandibular Joint Dislocation: A Comprehensive Review and Proposal of a Treatment Algorithm.Medicina (Kaunas, Lithuania) · 2025Review
- Ultrasound-guided intraoral botulinum toxin injection into the lateral pterygoid muscle for chronic temporomandibular joint dislocation.Journal of the Korean Association of Oral and Maxillofacial Surgeons · 2024Article
- A Narrative Review on Biologic Joint Therapy in Chronic Bilateral Mandibular Luxation : Biologic Joint Therapy in Chronic Bilateral Mandibular Luxation.Galen medical journal · 2024Review
- Superior Dislocation of the Mandibular Condyle into the Middle Cranial Fossa: A Comprehensive Review of the Literature.Journal of clinical medicine · 2023Review
- Review
- Article
- Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System.Toxins · 2022Review
- Ultrasound-Guided OnabotulinumtoxinA Injections to Treat Oromandibular Dystonia in Cerebral Palsy.Toxins · 2022Article
- Prevalence and incidence of oromandibular dystonia: an oral and maxillofacial surgery service-based study.Clinical oral investigations · 2021Article
- Article
- Velopharyngeal dysfunction following botulinum toxin type A injection to the lateral pterygoid muscles for recurrent jaw dislocation.BMJ case reports · 2021Article
- Positioning accuracy assessment of minimally invasive percutaneous injection techniques for the treatment of temporomandibular disorders.Dento maxillo facial radiology · 2021Article
- Article
- Development and Validation of a Disease-Specific Oromandibular Dystonia Rating Scale (OMDRS).Frontiers in neurology · 2020Article
- Observational
- Oromandibular dystonia unresponsive to botulinum toxin: two illustrative cases of condylar dislocation as a structural mimic.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The aim of this study was to compare treatment outcomes following intramuscular injection of botulinum neurotoxin (BoNT) in patients with recurrent temporomandibular joint dislocation, with and without muscle hyperactivity due to neurological diseases. Thirty-two patients (19 women and 13 men, mean age: 62.3 years) with recurrent temporomandibular joint dislocation were divided into two groups: neurogenic (8 women and 12 men) and habitual (11 women and 1 man). The neurogenic group included patients having neurological disorders, such as Parkinson’s disease or oromandibular dystonia, that are accompanied by muscle hyperactivity. BoNT was administered via intraoral injection to the inferior head of the lateral pterygoid muscle. In total, BoNT injection was administered 102 times (mean 3.2 times/patient). The mean follow-up duration was 29.5 months. The neurogenic group was significantly (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.